Matinas BioPharma Investor Presentation Deck
January 2024, 29 slides
  1. Matinas BioPharma
  2. Related Decks
  3. Investor Presentation Decks
corporate presentation | Matinas BioPharma
forward looking statements | Matinas BioPharma
investment thesis delivery unlocks therapeutic value mat pipeline products and opportunities oral administration of capabilities | Matinas BioPharma
a clinically validated intracellular delivery platform me ion | Matinas BioPharma
enables cellular targeting and intracellular delivery | Matinas BioPharma
mat oral clinical validation of delivery | Matinas BioPharma
the growing threat of invasive fungal infections | Matinas BioPharma
mat unlocking the full potential of mat is a promising potential therapeutic option potent only available through available systemically | Matinas BioPharma
enact phase clinical validation of safety and efficacy | Matinas BioPharma
results of enact published in highly regarded peer reviewed journal oral for meningitis a randomized clinical trial | Matinas BioPharma
mat expanded access program targeted treatment of throughout the body | Matinas BioPharma
mat expanded access compassionate use program demonstrated efficacy in treatment of patients with limited treatment options | Matinas BioPharma
compassionate use kidney toxicity with mat recovery from a a i | Matinas BioPharma
high unmet medical need in treatment of invasive aspergillosis | Matinas BioPharma
mat regulatory and development strategy | Matinas BioPharma
proposed phase study design in invasive aspergillosis | Matinas BioPharma
mat value proposition value oral administration of lack of nephrotoxicity safe long term oral step down maw mete calm cal | Matinas BioPharma
beyond mat efficient and safe delivery of small | Matinas BioPharma
therapeutic cargo experience to date | Matinas BioPharma
unlocking the full potential of the platform | Matinas BioPharma
in tumor cell inhibition with formulations rationale and next steps | Matinas BioPharma
in therapeutic efficacy of oral in a murine melanoma model | Matinas BioPharma
formulated small show strong uptake in innate immune cells support role in treating inflammation | Matinas BioPharma
effect of oral a in a murine psoriasis model | Matinas BioPharma
effect of oral in a murine acute colitis model i day | Matinas BioPharma
summary of recent key advances | Matinas BioPharma
expanding intellectual property portfolio continuingly increasing our patent suite to increase protection and exclusivity strong regulatory designations | Matinas BioPharma
experienced leadership team i the | Matinas BioPharma
investment thesis financial summary near term milestones setup for strong start to solid value foundation substantial upside | Matinas BioPharma
See More
Matinas BioPharma
Investor Presentation Decks
Biotechnology Decks
Healthcare Decks
Explore Topics
Delivery
Tumor
Recent decks by Matinas BioPharma
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
See all presentations by Matinas BioPharma (7 decks)
Related decks
Poseida Therapeutics
IPO
July 2020
Codiak
IPO
October 2020
RenovoRx
IPO
August 2021
Taysha
IPO
September 2020
MindMed
Investor Day
June 2023
Fusion Pharmaceuticals
Investor Presentation
January 2024
Genelux
Investor Presentation
February 2024
Enochian Biosciences
Investor Presentation
January 2024
Recent decks by Matinas BioPharma
See all presentations (7 decks)
Investor Presentation
March 2024
Investor Presentation
February 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Poseida Therapeutics
IPO
July 2020
Codiak
IPO
October 2020
RenovoRx
IPO
August 2021
Taysha
IPO
September 2020
MindMed
Investor Day
June 2023
Fusion Pharmaceuticals
Investor Presentation
January 2024
Genelux
Investor Presentation
February 2024
Enochian Biosciences
Investor Presentation
January 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io